Diligence memo · auto-generated · as of July 2, 2026
Advanced Cardiac Therapeutics Inc
Advanced Cardiac Therapeutics Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Advanced Cardiac Therapeutics Inc operates in Pharma, based in Santa Clara.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Advanced Cardiac Therapeutics Inc has raised $64M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $45M on 2017-05-01.
Most recent recorded round closed around 2017-05-01.
Valuation (modeled)modeled
Provath models Advanced Cardiac Therapeutics Inc at approximately $1.6B (range $146M–$4.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.99× the median modeled value of Series C Pharma companies in 2016–2018 (5 peers) — value vs value, same stage and era. Within the normal band (99% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 20 months.
Last raise 9.2 yr ago; this sector typically re-raises about every 16 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 6.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 87% of Pharma peers (310 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Prevail Therapeutics Inc., Celsius Therapeutics, Inc., Akero Therapeutics, Inc., Ovid Therapeutics Inc..
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.